stocks logo

NXL

Nexalin Technology Inc
$
0.900
0(0.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.900
Open
0.900
VWAP
0.90
Vol
2.65K
Mkt Cap
15.68M
Low
0.900
Amount
2.38K
EV/EBITDA(TTM)
--
Total Shares
7.59M
EV
9.88M
EV/OCF(TTM)
--
P/S(TTM)
65.53
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety, depression and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. It has also designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.
Show More
1 Analyst Rating
up Image
455.56% Upside
Wall Street analysts forecast NXL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NXL is 5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
up Image
455.56% Upside
Current: 0.900
sliders
Low
5.00
Averages
5.00
High
5.00
Maxim Group
Anthony Vendetti
Hold
to
Strong Buy
Upgrades
$5
2025-03-24
Reason
Maxim analyst Anthony Vendetti upgraded Nexalin Technology to Buy from Hold with a $5 price target.
Maxim Group
Anthony Vendetti
Strong Buy
to
Hold
Downgrades
n/a
2024-12-05
Reason
Maxim Group
Anthony Vendetti
Strong Buy
Initiates
$3
2024-10-09
Reason
Maxim analyst Anthony Vendetti initiated coverage of Nexalin Technology with a Buy rating and $3 price target.

Valuation Metrics

The current forward P/E ratio for Nexalin Technology Inc (NXL.O) is -1.61, compared to its 5-year average forward P/E of -1.80. For a more detailed relative valuation and DCF analysis to assess Nexalin Technology Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.80
Current PE
-1.61
Overvalued PE
0.54
Undervalued PE
-4.13

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
42.30
Current PS
20.24
Overvalued PS
95.46
Undervalued PS
-10.87

Financials

Annual
Quarterly
FY2025Q2
YoY :
+163.00%
70.59K
Total Revenue
FY2025Q2
YoY :
+24.97%
-1.62M
Operating Profit
FY2025Q2
YoY :
+23.21%
-1.58M
Net Income after Tax
FY2025Q2
YoY :
-41.18%
-0.10
EPS - Diluted
FY2025Q2
YoY :
-27.59%
-922.97K
Free Cash Flow
FY2025Q2
YoY :
-7.33%
67.65
Gross Profit Margin - %
FY2025Q2
YoY :
-2.23%
-2.46K
FCF Margin - %
FY2025Q2
YoY :
-53.20%
-2.24K
Net Margin - %

Trading Trends

Insider
Insiders areBuying! The selling amount has increased 117.11% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
13.2K
USD
Months
6-9
5
17.8K
USD
Months
0-12
1
1.1K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

NXL News & Events

Events Timeline

2025-08-01 (ET)
2025-08-01
08:34:49
Nexalin Technology appoints Justin Van Fleet as Chief Financial Officer
select
2025-05-13 (ET)
2025-05-13
08:34:45
Nexalin Technology reconstitutes Scientific Advisory Board
select
2025-05-05 (ET)
2025-05-05
08:24:10
Nexalin Technology prices 3.85M shares at $1.30 in public offering
select
Sign Up For More Events

News

5.0
08-01Newsfilter
Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives
1.0
05-28Newsfilter
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3
1.0
05-28Globenewswire
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3
Sign Up For More News

FAQ

arrow icon

What is Nexalin Technology Inc (NXL) stock price today?

The current price of NXL is 0.9 USD — it has increased 0 % in the last trading day.

arrow icon

What is Nexalin Technology Inc (NXL)'s business?

arrow icon

What is the price predicton of NXL Stock?

arrow icon

What is Nexalin Technology Inc (NXL)'s revenue for the last quarter?

arrow icon

What is Nexalin Technology Inc (NXL)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Nexalin Technology Inc (NXL)'s fundamentals?

arrow icon

How many employees does Nexalin Technology Inc (NXL). have?

arrow icon

What is Nexalin Technology Inc (NXL) market cap?